KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 66 filers reported holding KURA ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,276,000 | -7.7% | 228,318 | +2.7% | 1.36% | +18.3% |
| Q2 2021 | $4,634,000 | -23.2% | 222,263 | +4.1% | 1.15% | -6.0% |
| Q1 2021 | $6,035,000 | +39.7% | 213,471 | +61.4% | 1.22% | +38.6% |
| Q4 2020 | $4,320,000 | +350.5% | 132,283 | +322.9% | 0.88% | +365.3% |
| Q3 2020 | $959,000 | +37.8% | 31,283 | -26.7% | 0.19% | -6.4% |
| Q2 2020 | $696,000 | -65.7% | 42,683 | -70.4% | 0.20% | -72.5% |
| Q4 2018 | $2,028,000 | -84.1% | 144,411 | -80.1% | 0.74% | -83.1% |
| Q3 2018 | $12,727,000 | -16.5% | 727,258 | -13.2% | 4.37% | -48.2% |
| Q2 2018 | $15,244,000 | +23.7% | 837,604 | +27.4% | 8.43% | +13.8% |
| Q1 2018 | $12,326,000 | +105.5% | 657,411 | +67.7% | 7.41% | +118.9% |
| Q4 2017 | $5,998,000 | +45.5% | 392,027 | +42.2% | 3.38% | +58.2% |
| Q3 2017 | $4,122,000 | – | 275,731 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |